Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group

J. B. Kostis, B. R. Davis, J. Cutler, R. H. Grimm Jr, K. G. Berge, J. D. Cohen, C. R. Lacy, H. M. Perry Jr, M. D. Blaufox, S. Wassertheil-Smoller, H. R. Black, E. Schron, D. M. Berkson, J. D. Curb, W. M. Smith, R. McDonald and W. B. Applegate
Department of Medicine, Center for Disease Management and Clinical Outcomes, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ 08903-0019, USA. kostis@umdnj.edu

CONTEXT: Heart failure is often preceded by isolated systolic hypertension, but the effectiveness of antihypertensive treatment in preventing heart failure is not known. OBJECTIVE: To assess the effect of diuretic-based antihypertensive stepped-care treatment on the occurrence of heart failure in older persons with isolated systolic hypertension. DESIGN: Analysis of data from a multicenter, randomized, double-blind, placebo-controlled clinical trial. PARTICIPANTS: A total of 4736 persons aged 60 years and older with systolic blood pressure between 160 and 219 mm Hg and diastolic blood pressure below 90 mm Hg who participated in the Systolic Hypertension in the Elderly Program (SHEP). INTERVENTION: Stepped-care antihypertensive drug therapy, in which the step 1 drug is chlorthalidone (12.5-25 mg) or matching placebo, and the step 2 drug is atenolol (25-50 mg) or matching placebo. MAIN OUTCOME MEASURES: Fatal and nonfatal heart failure. RESULTS: During an average of 4.5 years of follow-up, fatal or nonfatal heart failure occurred in 55 of 2365 patients randomized to active therapy and 105 of the 2371 patients randomized to placebo (relative risk [RR], 0.51; 95% confidence interval [CI], 0.37-0.71; P<.001; number needed to treat to prevent 1 event [NNT], 48). Among patients with a history of or electrocardiographic evidence of prior myocardial infarction (MI), the RR was 0.19 (95% CI, 0.06-0.53; P=.002; NNT, 15). Older patients, men, and those with higher systolic blood pressure or a history of or electrocardiographic evidence of MI at baseline had higher risk of developing heart failure. CONCLUSION: In older persons with isolated systolic hypertension, stepped-care treatment based on low-dose chlorthalidone exerted a strong protective effect in preventing heart failure. Among patients with prior MI, an 80% risk reduction was observed.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group
Schocken et al.
Circulation 2008;117:2544-2565.
ABSTRACT | FULL TEXT  

Regression of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Less Hospitalization for Heart Failure in Hypertensive Patients
Okin et al.
ANN INTERN MED 2007;147:311-319.
ABSTRACT | FULL TEXT  

Diastolic heart failure--a common and lethal condition by any name.
Aurigemma
NEJM 2006;355:308-310.
FULL TEXT  

Role of Diuretics in the Prevention of Heart Failure: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Davis et al.
Circulation 2006;113:2201-2210.
ABSTRACT | FULL TEXT  

Antihypertensive Medication Use Among US Adults With Hypertension
Gu et al.
Circulation 2006;113:213-221.
ABSTRACT | FULL TEXT  

Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM
Assmann et al.
Eur Heart J 2005;26:2120-2126.
ABSTRACT | FULL TEXT  

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)
Developed in Collaboration With the American Colle et al.
J Am Coll Cardiol 2005;46:1116-1143.
FULL TEXT  

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society
Hunt et al.
Circulation 2005;112:1825-1852.
FULL TEXT  

Major Clinical Trials of Hypertension: What Should Be Done Next?
The National Heart, Lung, and Blood Institute Work
Hypertension 2005;46:1-6.
ABSTRACT | FULL TEXT  

Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults
Sutton-Tyrrell et al.
Circulation 2005;111:3384-3390.
ABSTRACT | FULL TEXT  

Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril
Wright et al.
JAMA 2005;293:1595-1608.
ABSTRACT | FULL TEXT  

Management of Hypertension in the Very Elderly Patient
Elliott
Hypertension 2004;44:800-804.
ABSTRACT | FULL TEXT  

Diastolic Heart Failure
Aurigemma and Gaasch
NEJM 2004;351:1097-1105.
FULL TEXT  

Meta-analysis of Health Outcomes of Chlorthalidone-Based vs Nonchlorthalidone-Based Low-Dose Diuretic Therapies
Psaty et al.
JAMA 2004;292:43-44.
FULL TEXT  

ALLHAT: Setting the Record Straight
Davis et al.
ANN INTERN MED 2004;141:39-46.
ABSTRACT | FULL TEXT  

New national guidelines on hypertension: A summary for dentistry
HERMAN et al.
Journal of the American Dental Association 2004;135:576-584.
ABSTRACT | FULL TEXT  

Hypertension and the Vascular Patient
Samson
VASC ENDOVASCULAR SURG 2004;38:103-119.
ABSTRACT  

Extent of Cardiovascular Risk Reduction Associated With Treatment of Isolated Systolic Hypertension
Sutton-Tyrrell et al.
Arch Intern Med 2003;163:2728-2731.
ABSTRACT | FULL TEXT  

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Chobanian et al.
Hypertension 2003;42:1206-1252.
ABSTRACT | FULL TEXT  

New definitions in cardiovascular risk management: is it time for angiotensin II receptor blockers to become first-line medication?
Jennings
Eur Heart J Suppl 2003;5:F3-F11.
ABSTRACT  

Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents: A Network Meta-analysis
Psaty et al.
JAMA 2003;289:2534-2544.
ABSTRACT | FULL TEXT  

Drug Therapy and Heart Failure Prevention
Linseman and Bristow
Circulation 2003;107:1234-1236.
FULL TEXT  

Systolic Blood Pressure, Diastolic Blood Pressure, and Pulse Pressure as Predictors of Risk for Congestive Heart Failure in the Framingham Heart Study
Haider et al.
ANN INTERN MED 2003;138:10-16.
ABSTRACT | FULL TEXT  

Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
The ALLHAT Officers and Coordinators for the ALLHA
JAMA 2002;288:2981-2997.
ABSTRACT | FULL TEXT  

Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study
Lloyd-Jones et al.
Circulation 2002;106:3068-3072.
ABSTRACT | FULL TEXT  

Relationship of Antihypertensive Treatment Regimens and Change in Blood Pressure to Risk for Heart Failure in Hypertensive Patients Randomly Assigned to Doxazosin or Chlorthalidone: Further Analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial
Davis et al.
ANN INTERN MED 2002;137:313-320.
ABSTRACT | FULL TEXT  

Guest Editorial: What Is the Appropriate Treatment of Hypertension in Elders?
Aronow
J. Gerontol. A Biol. Sci. Med. Sci. 2002;57:M483-486.
FULL TEXT  

Failing ageing hearts
Petrie et al.
Eur Heart J 2001;22:1978-1990.
 

Detection of Peripheral Arterial Disease in Primary Care
Ouriel
JAMA 2001;286:1380-1381.
FULL TEXT  

Drug treatment of isolated systolic hypertension
van Zwieten
Nephrol Dial Transplant 2001;16:1095-1097.
FULL TEXT  

Hypertension in Older Adults
Rigaud and Forette
J. Gerontol. A Biol. Sci. Med. Sci. 2001;56:217M-225.
ABSTRACT | FULL TEXT  

Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: The Cardiovascular Health Study
Aurigemma et al.
J Am Coll Cardiol 2001;37:1042-1048.
ABSTRACT | FULL TEXT  

Treatment of Congestive Heart Failure: Guidelines for the Primary Care Physician and the Heart Failure Specialist
Gomberg-Maitland et al.
Arch Intern Med 2001;161:342-352.
ABSTRACT | FULL TEXT  

There is a non-linear relationship between mortality and blood pressure
Port et al.
Eur Heart J 2000;21:1635-1638.
 

Controlling hypertension in the elderly
Jolobe
QJM 2000;93:700-701.
FULL TEXT  

Cost-effectiveness of the Lower Treatment Goal (of JNC VI) for Diabetic Hypertensive Patients
Elliott et al.
Arch Intern Med 2000;160:1277-1283.
ABSTRACT | FULL TEXT  

Predictors of congestive heart failure in the elderly: the cardiovascular health study
Gottdiener et al.
J Am Coll Cardiol 2000;35:1628-1637.
ABSTRACT | FULL TEXT  

Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
The ALLHAT Officers and Coordinators for the ALLHA
JAMA 2000;283:1967-1975.
ABSTRACT | FULL TEXT  

Reducing Antihypertensive Medication Use in Nursing Home Patients
Froom and Trilling
Arch Fam Med 2000;9:378-383.
ABSTRACT | FULL TEXT  

Hypertension in the Elderly: Can We Improve Results of Therapy?
Prisant and Moser
Arch Intern Med 2000;160:283-289.
ABSTRACT | FULL TEXT  

Renal Response to Acute Neutral Endopeptidase Inhibition in Mild and Severe Experimental Heart Failure
Chen et al.
Circulation 1999;100:2443-2448.
ABSTRACT | FULL TEXT  

Reduced Coronary Events in Simvastatin-Treated Patients With Coronary Heart Disease and Diabetes or Impaired Fasting Glucose Levels: Subgroup Analyses in the Scandinavian Simvastatin Survival Study
Haffner et al.
Arch Intern Med 1999;159:2661-2667.
ABSTRACT | FULL TEXT  

The care of patients with diabetic nephropathy: audit, feedback, and improvement
Dunn et al.
QJM 1999;92:443-449.
ABSTRACT | FULL TEXT  

Increased Pulse Pressure and Risk of Heart Failure in the Elderly
Chae et al.
JAMA 1999;281:634-643.
ABSTRACT | FULL TEXT  

Congestive Heart Failure in the Community: Trends in Incidence and Survival in a 10-Year Period
Senni et al.
Arch Intern Med 1999;159:29-34.
ABSTRACT | FULL TEXT  

Use of echocardiography in the management of congestive heart failure in the community
Senni et al.
J Am Coll Cardiol 1999;33:164-170.
ABSTRACT | FULL TEXT  

Prevalence, Clinical Correlates, and Treatment of Hypertension in Elderly Nursing Home Residents
Gambassi et al.
Arch Intern Med 1998;158:2377-2385.
ABSTRACT | FULL TEXT  

Blood pressure and mortality in elderly people aged 85 and older: community based study
Boshuizen et al.
BMJ 1998;316:1780-1784.
ABSTRACT | FULL TEXT  

Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald
NEJM 1997;337:1360-1369.
FULL TEXT  

Antihypertensive Treatment Prevents Heart Failure
Journal Watch Cardiology 1997;1997:4-4.
FULL TEXT  

STEPPED HYPERTENSION CARE HELPS PREVENT HEART FAILURE
JWatch General 1997;1997:2-2.
FULL TEXT